Nxera Pharma Co., Ltd.
4565.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥32,268,000 | ¥49,065,000 | ¥66,557,000 | ¥60,087,000 |
| Short-Term Investments | ¥3,935,000 | ¥0 | ¥0 | ¥86,000 |
| Receivables | ¥6,695,000 | ¥5,064,000 | ¥2,462,000 | ¥2,138,000 |
| Inventory | ¥8,838,000 | ¥2,903,000 | ¥32,000 | -¥33,000 |
| Other Curr. Assets | ¥6,119,000 | ¥8,080,000 | ¥891,000 | ¥530,000 |
| Total Curr. Assets | ¥57,855,000 | ¥65,112,000 | ¥69,942,000 | ¥62,808,000 |
| Property Plant & Equip (Net) | ¥7,468,000 | ¥7,900,000 | ¥3,791,000 | ¥3,817,000 |
| Goodwill | ¥25,693,000 | ¥24,623,000 | ¥15,306,000 | ¥15,095,000 |
| Intangibles | ¥51,911,000 | ¥52,291,000 | ¥8,577,000 | ¥9,120,000 |
| Long-Term Investments | ¥4,518,000 | ¥3,266,000 | ¥1,737,000 | ¥5,957,000 |
| Tax Assets | ¥4,021,000 | ¥3,964,000 | ¥806,000 | ¥86,000 |
| Other NC Assets | ¥32,000 | ¥42,000 | -¥742,000 | ¥102,000 |
| Total NC Assets | ¥93,643,000 | ¥92,086,000 | ¥29,475,000 | ¥34,177,000 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥151,498,000 | ¥157,198,000 | ¥99,417,000 | ¥96,985,000 |
| Liabilities | – | – | – | – |
| Payables | ¥4,052,000 | ¥4,244,000 | ¥1,628,000 | ¥1,176,000 |
| Short-Term Debt | ¥6,690,000 | ¥6,773,000 | ¥352,000 | ¥386,000 |
| Tax Payable | ¥255,000 | ¥378,000 | ¥260,000 | ¥279,000 |
| Deferred Revenue | ¥0 | ¥0 | ¥1,450,000 | ¥785,000 |
| Other Curr. Liab. | ¥4,635,000 | ¥5,790,000 | ¥402,000 | ¥4,565,000 |
| Total Curr. Liab. | ¥15,632,000 | ¥17,185,000 | ¥4,092,000 | ¥7,191,000 |
| LT Debt | ¥61,210,000 | ¥67,200,000 | ¥29,558,000 | ¥29,078,000 |
| Deferred Rev, NC | ¥3,776,000 | ¥3,882,000 | ¥4,791,000 | ¥384,000 |
| Deferred Tax Liab, NC | ¥1,857,000 | ¥1,490,000 | ¥2,922,000 | ¥2,706,000 |
| Other NC Liab. | ¥505,000 | ¥631,000 | ¥118,000 | ¥111,000 |
| Total NC Liab. | ¥67,348,000 | ¥73,203,000 | ¥37,389,000 | ¥32,326,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥4,375,000 | ¥4,817,000 | ¥1,753,000 | ¥1,831,000 |
| Total Liabilities | ¥82,980,000 | ¥90,388,000 | ¥41,481,000 | ¥39,517,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥47,172,000 | ¥46,807,000 | ¥41,335,000 | ¥41,036,000 |
| Retained Earnings | -¥20,942,000 | -¥16,104,000 | -¥8,911,000 | -¥9,768,000 |
| AOCI | ¥7,217,000 | ¥2,060,000 | -¥4,012,000 | -¥2,900,000 |
| Other Equity | ¥35,071,000 | ¥34,047,000 | ¥25,512,000 | ¥26,200,000 |
| Total Equity | ¥68,518,000 | ¥66,810,000 | ¥57,936,000 | ¥57,468,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥151,498,000 | ¥157,198,000 | ¥99,417,000 | ¥96,985,000 |
| Net Debt | ¥35,632,000 | ¥24,908,000 | -¥36,647,000 | -¥30,623,000 |